Overview of FDA Expedited Development and Approval Programs for Serious Conditions
Impact Pharmaceutical Services
MAY 4, 2022
May 4, 2022 | Nathaniel DiTommaso, MS, Regulatory Affairs Manager. Syner-G has experienced regulatory affairs professionals that can provide you with expert consultation and strategic planning. Category: Regulatory Affairs , Drug Development Consulting. Image courtesy of qimono at pixabay.com.
Let's personalize your content